Project Grant R01CA292971
Award Date
9/9/24
Completion Date
8/31/29
Dollars Obligated
$693K
Federal Agency
National Cancer Institute
Federal Grant Program
93.393
Assistance Type
Project Grant
Place of Performance
San Francisco, CA 94143, USA
Similar Awards
The National Cancer Institute (NCI) awarded a $1,698,536 Project Grant (CFDA 93.393 - Cancer Cause and Prevention Research) to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), to develop and test a remote, young adult lay-counselor delivered behavioral and digital intervention called "QuitVaping" to promote nicotine vaping cessation and prevent escalation of tobacco use among youth aged 14-18. The project will enroll 300 adolescents who vape...
The National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) awarded a $247,433 Project Grant to the University of Nebraska Medical Center (UNMC) for the "Parents Helping Parents for Youth Vaping Cessation (PHP-VX)" program. The goal of this feasibility study is to develop and test a parent-facilitated youth vaping cessation intervention, which will include online training sessions and weekly parent-to-parent support. A key sub-award of $34,102 was made to the...
The National Cancer Institute (NCI) awarded a $257,415 Project Grant under the Cancer Cause and Prevention Research (CFDA 93.393) program to The Research Foundation for the State University of New York (RF SUNY) to develop an AI-enhanced smartphone app-based intervention for adolescent e-cigarette cessation. The goal is to create a scalable, cost-effective intervention that uses AI-assisted user profiling and personalized content to help adolescents quit e-cigarettes. The 3-year project will...
This $310,319 Project Grant award from the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research (CFDA 93.393) program will support the University of Louisville in conducting formative research to develop a motivation-based adolescent vaping typology to inform the development of tailored cognitive behavioral e-cigarette cessation interventions. The key objectives are to: 1) identify different types of adolescent e-cigarette users based on their motivations for use, 2)...
This Project Grant award, funded by the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research (CFDA 93.393) program, supports a research project to identify key features of e-cigarette-related social media posts that are associated with high user engagement. The goal is to provide guidance for designing effective vaping prevention messages for future public health campaigns to help communicate the risks of e-cigarette use and prevent youth and young adult initiation...
This Project Grant award from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) will fund a randomized controlled trial to examine the efficacy of a smartphone app called "Kick-Nic!" for e-cigarette cessation among 306 high school adolescents. The app provides an engaging, multimedia-rich, and interactive cognitive-behavioral therapy platform to help adolescents develop coping skills for e-cigarette-specific triggers and support their cessation efforts....
This federal Project Grant award of $619,175 from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) supports a Type 1 hybrid effectiveness-implementation trial to evaluate a novel harm reduction approach for oncology outpatients who smoke but refuse traditional tobacco treatment. The study will directly compare rates of switching from cigarettes to e-cigarettes against standard care, while also assessing key barriers and facilitators to implementation. The...
This Project Grant award from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) will provide $687,995.00 to Yale University to conduct a randomized clinical trial investigating the efficacy of varenicline for quitting e-cigarette use in adults. The project aims to 1) compare the effect of varenicline versus placebo on e-cigarette quit rates, 2) test predictors and moderators of outcomes, and 3) explore changes in cancer-related biomarkers following e-cigarette...
This Project Grant award from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) provides $407,581.00 to Texas Christian University to conduct a longitudinal study examining the relationships between social media engagement and the use and dependence on electronic nicotine delivery systems (ENDS) among young adults. The study aims to identify the cognitive factors that mediate these associations, as well as intrapersonal and interpersonal moderators. The project...
The National Cancer Institute (NCI) awarded a Project Grant under the Cancer Cause and Prevention Research program (CFDA 93.393) to the University of Oklahoma Health Sciences Center to conduct a randomized factorial trial on smoking cessation interventions. The $625,201 award, effective January 1, 2025 through December 31, 2029, will evaluate the combined impact of varenicline medication plus nicotine lozenges, and a smartphone-based medication adherence intervention, on 7-day point prevalence...